{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:40:18Z","timestamp":1762353618980,"version":"3.41.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Patient-Centered Clinical Research Coordinating Center (PACEN), Ministry of Health & Welfare, Republic of Korea","award":["RS-2021-KH119931"],"award-info":[{"award-number":["RS-2021-KH119931"]}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00340590"],"award-info":[{"award-number":["RS-2024-00340590"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Atrial fibrillation (AF) frequently coexists with diabetes mellitus (DM), leading to a worse prognosis if both are present. Steatotic liver disease (SLD) may also predispose to DM, but its impact among AF patients is unclear. We aimed to determine whether metabolic dysfunction-associated SLD (MASLD), MASLD with increased alcohol intake (MetALD), or alcohol-related liver disease (ALD) elevates DM risk in AF.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Non-diabetic individuals who developed AF between 2010 and 2018 from the Korean National Health Insurance Service database were included. Patients with a fatty liver index (FLI)\u2009&lt;\u200930 were classified as non-SLD, whereas those with FLI\u2009\u2265\u200930 and at least one cardiometabolic risk factors were categorized as MASLD, MetALD, or ALD based on daily alcohol intake. Incident DM hazard ratios (HRs) were estimated with Cox regression models.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among 195,195 patients (mean age 64.4\u2009\u00b1\u200913.0 years, 57.5% male); 108,918 (55.8%) in non-SLD, 71,795 (36.8%) in MASLD, 7644 (3.9%) in MetALD, and 6838 (3.5%) in ALD, respectively. Over a mean follow-up of 6.0\u2009\u00b1\u20092.9 years, 25,632 (13.0%) developed DM. Compared with non-SLD, the adjusted HRs with 95% confidence intervals (CIs) for incident DM were 1.930 (1.879\u20131.983), 1.789 (1.682\u20131.904), and 1.932 (1.817\u20132.054) for MASLD, MetALD, and ALD, respectively. In the age 20\u201339 years group, adjusted HRs with 95% CIs were 5.844 (4.501\u20137.587), 5.354 (3.681\u20137.787), and 7.033 (4.660\u201310.615), respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>SLD confers an increased risk of new-onset DM in AF patients, especially in younger adults. Implementing management strategies to prevent DM in AF patients with SLD might mitigate the risk of DM and its potential impact on AF-related outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s12933-025-02795-5","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T04:40:17Z","timestamp":1749271217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of steatotic liver diseases on diabetes mellitus risk in patients with atrial fibrillation: a nationwide population study"],"prefix":"10.1186","volume":"24","author":[{"given":"Hyunho","family":"Ryu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"So-Ryoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eue-Keun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Hae","family":"Go","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Yeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JungMin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seokmoon","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyo-Jeong","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soonil","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bong-Seoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Do","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seil","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,7]]},"reference":[{"issue":"25","key":"2795_CR1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2795_CR2","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41569-022-00820-8","volume":"20","author":"AD Elliott","year":"2023","unstructured":"Elliott AD, Middeldorp ME, Van Gelder IC, Albert CM, Sanders P. Epidemiology and modifiable risk factors for atrial fibrillation. Nat Rev Cardiol. 2023;20(6):404\u201317.","journal-title":"Nat Rev Cardiol"},{"key":"2795_CR3","doi-asserted-by":"publisher","first-page":"100786","DOI":"10.1016\/j.lanepe.2023.100786","volume":"37","author":"D Linz","year":"2024","unstructured":"Linz D, Gawalko M, Betz K, Hendriks JM, Lip GY, Vinter N, Guo Y, Johnsen S. Atrial fibrillation: epidemiology, screening and digital health. Lancet Reg Health Eur. 2024;37:100786.","journal-title":"Lancet Reg Health Eur"},{"issue":"11","key":"2795_CR4","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.jacc.2017.07.755","volume":"70","author":"JB Echouffo-Tcheugui","year":"2017","unstructured":"Echouffo-Tcheugui JB, Shrader P, Thomas L, Gersh BJ, Kowey PR, Mahaffey KW, Singer DE, Hylek EM, Go AS, Peterson ED. Care patterns and outcomes in atrial fibrillation patients with and without diabetes: ORBIT-AF registry. J Am Coll Cardiol. 2017;70(11):1325\u201335.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"2795_CR5","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1093\/europace\/euab184","volume":"23","author":"L Fauchier","year":"2021","unstructured":"Fauchier L, Boriani G, de Groot JR, Kreutz R, Rossing P, Camm AJ. Medical therapies for prevention of cardiovascular and renal events in patients with atrial fibrillation and diabetes mellitus. EP Europace. 2021;23(12):1873\u201391.","journal-title":"EP Europace"},{"key":"2795_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.amjcard.2020.06.049","volume":"131","author":"SH Patlolla","year":"2020","unstructured":"Patlolla SH, Lee H-C, Noseworthy PA, Wysokinski WE, Hodge DO, Greene EL, Gersh BJ, Melduni RM. Impact of diabetes mellitus on stroke and survival in patients with atrial fibrillation. Am J Cardiol. 2020;131:33\u20139.","journal-title":"Am J Cardiol"},{"issue":"9","key":"2795_CR7","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/eurheartj\/ehp055","volume":"30","author":"X Du","year":"2009","unstructured":"Du X, Ninomiya T, De Galan B, Abadir E, Chalmers J, Pillai A, Woodward M, Cooper M, Harrap S, Hamet P. Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the advance study. Eur Heart J. 2009;30(9):1128\u201335.","journal-title":"Eur Heart J"},{"issue":"12","key":"2795_CR8","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.2337\/dc23-0931","volume":"46","author":"S Kwon","year":"2023","unstructured":"Kwon S, Lee S-R, Choi E-K, Ahn H-J, Lee S-W, Jung J-H, Han K-D, Oh S, Lip GY. Association between atrial fibrillation and diabetes-related complications: a nationwide cohort study. Diabetes Care. 2023;46(12):2240\u20138.","journal-title":"Diabetes Care"},{"issue":"1","key":"2795_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s42444-021-00057-5","volume":"23","author":"S Rafaqat","year":"2022","unstructured":"Rafaqat S, Rafaqat S, Rafaqat S. Pathophysiological aspects of insulin resistance in atrial fibrillation: novel therapeutic approaches. Int J Arrhythm. 2022;23(1):6.","journal-title":"Int J Arrhythm"},{"issue":"10464","key":"2795_CR10","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/S0140-6736(24)01811-7","volume":"404","author":"M Israelsen","year":"2024","unstructured":"Israelsen M, Francque S, Tsochatzis EA, Krag A. Steatotic liver disease. Lancet. 2024;404(10464):1761\u201378.","journal-title":"Lancet"},{"issue":"6","key":"2795_CR11","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966\u201386.","journal-title":"Hepatology"},{"issue":"3","key":"2795_CR12","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/liv.13994","volume":"39","author":"AE Morrison","year":"2019","unstructured":"Morrison AE, Zaccardi F, Khunti K, Davies MJ. Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes: a meta\u2010analysis with bias analysis. Liver Int. 2019;39(3):557\u201367.","journal-title":"Liver Int"},{"issue":"1","key":"2795_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.23838\/pfm.2021.00135","volume":"6","author":"DW Shin","year":"2022","unstructured":"Shin DW, Cho J, Park JH, Cho B. National general health screening program in Korea: history, current status, and future direction. Precis Future Med. 2022;6(1):9\u201331.","journal-title":"Precis Future Med"},{"issue":"9","key":"2795_CR14","doi-asserted-by":"publisher","first-page":"754","DOI":"10.4070\/kcj.2020.0171","volume":"50","author":"E-K Choi","year":"2020","unstructured":"Choi E-K. Cardiovascular research using the Korean national health information database. Korean Circulation J. 2020;50(9):754\u201372.","journal-title":"Korean Circulation J"},{"key":"2795_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:1\u20137.","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"2795_CR16","doi-asserted-by":"publisher","first-page":"e1095","DOI":"10.1210\/clinem\/dgad575","volume":"109","author":"H Kwon","year":"2024","unstructured":"Kwon H, Han K-D, Moon SJ, Park SE, Rhee E-J, Lee W-Y. Nonalcoholic fatty liver disease and the risk of thyroid cancer among young adults in South Korea. J Clin Endocrinol Metab. 2024;109(3):e1095\u2013104.","journal-title":"J Clin Endocrinol Metab"},{"key":"2795_CR17","doi-asserted-by":"publisher","first-page":"832023","DOI":"10.3389\/fcvm.2022.832023","volume":"9","author":"J Choi","year":"2022","unstructured":"Choi J, Lee S-R, Choi E-K, Ahn H-J, Kwon S, Park S-H, Lee H, Chung J, Han M, Lee S-W. Non-alcoholic fatty liver disease and the risk of incident atrial fibrillation in young adults: a nationwide population-based cohort study. Front Cardiovasc Med. 2022;9:832023.","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"2795_CR18","first-page":"533","volume":"73","author":"H-H Lee","year":"2024","unstructured":"Lee H-H, Lee HA, Kim E-J, Kim HY, Kim HC, Ahn SH, Lee H, Kim SU. Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease. Gut. 2024;73(3):533\u201340.","journal-title":"Gut"},{"issue":"12","key":"2795_CR19","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.3390\/diagnostics11122233","volume":"11","author":"E-J Cho","year":"2021","unstructured":"Cho E-J, Jung G-C, Kwak M-S, Yang J-I, Yim J-Y, Yu S-J, Chung G-E. Fatty liver index for predicting nonalcoholic fatty liver disease in an asymptomatic Korean population. Diagnostics. 2021;11(12):2233.","journal-title":"Diagnostics"},{"issue":"40","key":"2795_CR20","doi-asserted-by":"publisher","first-page":"e1682","DOI":"10.1097\/MD.0000000000001682","volume":"94","author":"X Huang","year":"2015","unstructured":"Huang X, Xu M, Chen Y, Peng K, Huang Y, Wang P, Ding L, Lin L, Xu Y, Chen Y, et al. Validation of the fatty liver index for nonalcoholic fatty liver disease in middle-aged and elderly Chinese. Medicine. 2015;94(40):e1682.","journal-title":"Medicine"},{"issue":"2","key":"2795_CR21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.7570\/jomes22024","volume":"31","author":"YS Yang","year":"2022","unstructured":"Yang YS, Han B-D, Han K, Jung J-H, Son JW. Obesity fact sheet in Korea, 2021: trends in obesity prevalence and obesity-related comorbidity incidence stratified by age from 2009 to 2019. J Obes Metab Syndr. 2022;31(2):169.","journal-title":"J Obes Metab Syndr"},{"issue":"5","key":"2795_CR22","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1097\/HEP.0000000000000670","volume":"79","author":"F Kanwal","year":"2024","unstructured":"Kanwal F, Neuschwander-Tetri BA, Loomba R, Rinella ME. Metabolic dysfunction\u2013associated steatotic liver disease: update and impact of new nomenclature on the American Association for the study of liver diseases practice guidance on nonalcoholic fatty liver disease. Hepatology. 2024;79(5):1212\u20139.","journal-title":"Hepatology"},{"issue":"5","key":"2795_CR23","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.cgh.2024.01.006","volume":"22","author":"P Nasr","year":"2024","unstructured":"Nasr P, Wester A, Ekstedt M, Strandberg R, Kechagias S, Shang Y, Widman L, Hagstr\u00f6m H. Misclassified alcohol-related liver disease is common in presumed metabolic dysfunction-associated steatotic liver disease and highly increases risk for future cirrhosis. Clin Gastroenterol Hepatol. 2024;22(5):1048\u201357.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"2795_CR24","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.jhep.2024.11.028","volume":"82","author":"JP Arab","year":"2024","unstructured":"Arab JP, D\u00edaz LA, Rehm J, Im G, Arrese M, Kamath PS, Lucey MR, Mellinger J, Thiele M, Thursz M et al. Metabolic dysfunction and alcohol-related liver disease (MetALD): position statement by an expert panel on alcohol-related liver disease. J Hepatol. 2024;82(4):744\u2013756.","journal-title":"J Hepatol"},{"key":"2795_CR25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41575-024-01022-y","volume":"22","author":"N Torp","year":"2025","unstructured":"Torp N, Israelsen M, Krag A. The steatotic liver disease burden paradox: unravelling the key role of alcohol. Nat Rev Gastroenterol Hepatol. 2025;22:281\u201392.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"2795_CR26","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq433","volume":"173","author":"H Quan","year":"2011","unstructured":"Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, Januel J-M, Sundararajan V. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676\u201382.","journal-title":"Am J Epidemiol"},{"issue":"2","key":"2795_CR27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GY Lip","year":"2010","unstructured":"Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro heart survey on atrial fibrillation. Chest. 2010;137(2):263\u201372.","journal-title":"Chest"},{"issue":"5","key":"2795_CR28","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1378\/chest.10-0134","volume":"138","author":"R Pisters","year":"2010","unstructured":"Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro heart survey. Chest. 2010;138(5):1093\u2013100.","journal-title":"Chest"},{"key":"2795_CR29","doi-asserted-by":"publisher","first-page":"e00009924","DOI":"10.1590\/0102-311xen009924","volume":"40","author":"GW Lopes","year":"2024","unstructured":"Lopes GW, Canhada SL, Reis RCPd, Diniz MFHS, Goulart AC, Faria LC, Griep RH, Perazzo H, Duncan BB, Schmidt MI. Comparing diabetes prediction based on metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease: the ELSA-Brasil study. Cad Sa\u00fade P\u00fablica. 2024;40:e00009924.","journal-title":"Cad Sa\u00fade P\u00fablica"},{"issue":"5","key":"2795_CR30","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1136\/gutjnl-2020-322572","volume":"70","author":"A Mantovani","year":"2021","unstructured":"Mantovani A, Petracca G, Beatrice G, Tilg H, Byrne CD, Targher G. Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals. Gut. 2021;70(5):962\u20139.","journal-title":"Gut"},{"issue":"5","key":"2795_CR31","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/jgh.13264","volume":"31","author":"S Ballestri","year":"2016","unstructured":"Ballestri S, Zona S, Targher G, Romagnoli D, Baldelli E, Nascimbeni F, Roverato A, Guaraldi G, Lonardo A. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis. J Gastroenterol Hepatol. 2016;31(5):936\u201344.","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"2795_CR32","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1002\/hep.25539","volume":"55","author":"R Lomonaco","year":"2012","unstructured":"Lomonaco R, Ortiz-Lopez C, Orsak B, Webb A, Hardies J, Darland C, Finch J, Gastaldelli A, Harrison S, Tio F. Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease. Hepatology. 2012;55(5):1389\u201397.","journal-title":"Hepatology"},{"issue":"6","key":"2795_CR33","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","volume":"14","author":"E Sunny Nishanth","year":"2011","unstructured":"Sunny Nishanth E, Parks Elizabeth J, Browning Jeffrey D, Burgess Shawn C. Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metabol. 2011;14(6):804\u201310.","journal-title":"Cell Metabol"},{"key":"2795_CR34","doi-asserted-by":"publisher","first-page":"1050049","DOI":"10.3389\/fendo.2023.1050049","volume":"14","author":"Y Tan","year":"2023","unstructured":"Tan Y, He Q, Chan KHK. Identification of shared genetic architecture between non-alcoholic fatty liver disease and type 2 diabetes: a genome-wide analysis. Front Endocrinol. 2023;14:1050049.","journal-title":"Front Endocrinol"},{"key":"2795_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2024.111584","volume":"212","author":"J Ha","year":"2024","unstructured":"Ha J, Hong O-K, Han K, Kwon H-S. Metabolic dysfunction-associated fatty liver disease increases the risk of type 2 diabetes mellitus in young Korean adults. Diabetes Res Clin Pract. 2024;212:111584.","journal-title":"Diabetes Res Clin Pract"},{"issue":"8","key":"2795_CR36","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1161\/STROKEAHA.115.009371","volume":"46","author":"TF Overvad","year":"2015","unstructured":"Overvad TF, Skj\u00f8th F, Lip GY, Lane DA, Albertsen IE, Rasmussen LH, Larsen TB. Duration of diabetes mellitus and risk of thromboembolism and bleeding in atrial fibrillation: nationwide cohort study. Stroke. 2015;46(8):2168\u201374.","journal-title":"Stroke"},{"issue":"4","key":"2795_CR37","doi-asserted-by":"publisher","first-page":"e023643","DOI":"10.1161\/JAHA.121.023643","volume":"11","author":"H Abdel-Qadir","year":"2022","unstructured":"Abdel-Qadir H, Gunn M, Lega IC, Pang A, Austin PC, Singh SM, Jackevicius CA, Tu K, Dorian P, Lee DS. Association of diabetes duration and glycemic control with stroke rate in patients with atrial fibrillation and diabetes: a population\u2010based cohort study. J Am Heart Assoc. 2022;11(4):e023643.","journal-title":"J Am Heart Assoc"},{"issue":"36","key":"2795_CR38","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns HJGM, De Potter TJR, Dwight J, Guasti L, Hanke T, et al. 2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO). Eur Heart J. 2024;45(36):3314\u2013414.","journal-title":"Eur Heart J"},{"issue":"1","key":"2795_CR39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1055\/s-0041-1739411","volume":"122","author":"TF Chao","year":"2022","unstructured":"Chao TF, Joung B, Takahashi Y, Lim TW, Choi EK, Chan YH, Guo Y, Sriratanasathavorn C, Oh S, Okumura K, et al. 2021 focused update consensus guidelines of the Asia Pacific heart rhythm society on stroke prevention in atrial fibrillation: executive summary. Thromb Haemost. 2022;122(1):20\u201347.","journal-title":"Thromb Haemost"},{"issue":"10","key":"2795_CR40","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1055\/a-2325-5923","volume":"124","author":"Y Wang","year":"2024","unstructured":"Wang Y, Guo Y, Qin M, Fan J, Tang M, Zhang X, Wang H, Li X, Lip GYH, Expert R. 2024 Chinese expert consensus guidelines on the diagnosis and treatment of atrial fibrillation in the elderly, endorsed by geriatric society of Chinese Medical Association (Cardiovascular Group) and Chinese Society of Geriatric Health Medicine (Cardiovascular Branch): executive summary. Thromb Haemost. 2024;124(10):897\u2013911.","journal-title":"Thromb Haemost"},{"key":"2795_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2023.101182","volume":"29","author":"C del Maldonado-Rojas","year":"2024","unstructured":"del Maldonado-Rojas C, Zuarth-V\u00e1zquez A, Uribe JM, Barbero-Becerra M. Insulin resistance and metabolic dysfunction-associated steatotic liver disease (MASLD): pathways of action of hypoglycemic agents. Ann Hepatol. 2024;29:101182.","journal-title":"Ann Hepatol"},{"issue":"12","key":"2795_CR42","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","volume":"384","author":"PN Newsome","year":"2021","unstructured":"Newsome PN, Buchholtz K, Cusi K, Linder M, Okanoue T, Ratziu V, Sanyal AJ, Sejling A-S, Harrison SA. A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis. N Engl J Med. 2021;384(12):1113\u201324.","journal-title":"N Engl J Med"},{"key":"2795_CR43","doi-asserted-by":"publisher","unstructured":"Kim MH, Yang PS, Kim D, Jang E, Yu HT, Kim TH, Sung JH, Pak HN, Lee MH, Lip GYH et al. Racial differences and similarities in atrial fibrillation epidemiology and risk factors in UK biobank and Korean NHIS-HEALS cohort studies. Heart Rhythm. 2025. https:\/\/doi.org\/10.1016\/j.hrthm.2025.02.013.","DOI":"10.1016\/j.hrthm.2025.02.013"},{"issue":"9","key":"2795_CR44","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1055\/a-2278-8769","volume":"124","author":"DS Kang","year":"2024","unstructured":"Kang DS, Yang PS, Kim D, Jang E, Yu HT, Kim TH, Sung JH, Pak HN, Lee MH, Lip GYH, et al. Racial differences in ischemic and hemorrhagic stroke: an ecological epidemiological study. Thromb Haemost. 2024;124(9):883\u201392.","journal-title":"Thromb Haemost"},{"issue":"5","key":"2795_CR45","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1007\/s11606-010-1609-1","volume":"26","author":"WH Shrank","year":"2011","unstructured":"Shrank WH, Patrick AR, Brookhart MA. Healthy user and related biases in observational studies of preventive interventions: a primer for physicians. J Gen Intern Med. 2011;26(5):546\u201350.","journal-title":"J Gen Intern Med"},{"issue":"Supplement1","key":"2795_CR46","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.2337\/dc25-S002","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","unstructured":"American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: standards of care in diabetes\u20142025. Diabetes Care. 2025;48(Supplement1):S27\u201349.","journal-title":"Diabetes Care"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02795-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02795-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02795-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T17:01:46Z","timestamp":1749315706000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02795-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,7]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2795"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02795-5","relation":{},"ISSN":["1475-2840"],"issn-type":[{"type":"electronic","value":"1475-2840"}],"subject":[],"published":{"date-parts":[[2025,6,7]]},"assertion":[{"value":"31 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the World Medical Association Declaration of Helsinki. The Institutional Review Board at the Seoul National University Hospital (E-2412-101-1597) authorized this study. Informed consent was waived since anonymous and deidentified information was used for analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"These authors disclose the following: E-K.C. reports research grants or speaking fees from Abbott, Bayer, BMS\/Pfizer, Biosense Webster, Chong Kun Dang, Daewoong Pharmaceutical Co., Daiichi-Sankyo, DeepQure, Dreamtech Co., Ltd., Jeil Pharmaceutical Co. Ltd, Medtronic, Samjinpharm, Samsung Electronics Co., Ltd., Seers Technology, Skylabs, and Yuhan Corporation. G.Y.H.L. reports consultant and speaker for BMS\/Pfizer, Boehringer Ingelheim, Anthos and Daiichi-Sankyo. No fees are received personally. The remaining authors disclose no conflicts.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"242"}}